Abstract
Purpose: Approximately 20 to 50 % of cAVMs treated by Radiosurgery (RS) fail to obliterate 2 to 5 years after a first Radiosurgery (RS1).Therefore the patients are not protected against the risks that were the very reasons for treatment. To eradicate the persisting nidus, a second RS (RS2) is an option for salvage treatment. We will evaluate this option in 39 pts initially treated by our group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
